News
The US dollar was mixed last week. One would have thought, based on the geopolitical tensions, the stronger-than-expected US economic data resulted in upward...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
Follow Play Earnings CallPlay Earnings Call Cogent Communications Holdings, Inc. (NASDAQ:CCOI) Bank of America 2025 Media, Communications & Entertainment Conference September 4, 2025 11:20...
News
This article was written by Follow An economics graduate with a passion for financial history; I apply my knowledge to markets in an effort...
News
This article was written by Follow Dhierin-Perkash Bechai is an aerospace, defense and airline analyst. Dhierin runs the investing group The Aerospace Forum, whose...
News
After almost 3 years of full lockdown, Macao’s casinos finally opened in full in 2023. Their economy is mostly founded on tourism and in...
News
Emerging market central banks responded quicker to inflation and remain in better shape financially than developed markets, and EM bonds may add resilience to...
News
Back in February, I place a “Buy” rating on CarGurus (NASDAQ:CARG), arguing that its results were being muddied by issues at CarOffer, but that...
News
A Barbell Maturity Structure Can Capture High Front- and Back-End Yields Historical and current analyses do not guarantee future results. For illustrative purposes only....
News
In September of 2017, I received slightly over $100K from my former employer, representing the commuted value of my pension plan. I decided to...
News
Why Anta? Global sportswear leaders like Nike (NKE) and Adidas (OTCQX:ADDYY) have been able to generate high ROICs (>20%) in their peak years. I...
News
In January, I rated Energizer Holdings (NYSE:ENR) a hold and remarked that it was okay to take profits. I followed my advice and was...
News
Preformed Line Products Company (NASDAQ:PLPC) has notable and well-covered tailwinds from U.S. infrastructure spending. For a business like Preformed Line Products (“PLP”) that sells...
News
Topline Summary Xencor, Inc (NASDAQ:XNCR) is a biotechnology company mainly focused on the development and commercialization of anticancer medications. Through various successful partnerships, they...
